Taken together, our findings suggest a model in which miR-363-3p regulates both the mTOR/Cyclin D1 pathway and the Erk-cyclin D1 pathway to inhibit tumor cell growth (Figure 4C). The gene discussed is CCND1; the disease is neoplasm.